---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-142317"
form_type: "8-K"
ticker: "IKT"
cik: "0001750149"
company_name: "Inhibikase Therapeutics, Inc."
filed_at: "2024-05-20T23:59:59+00:00"
generated_at: "2026-06-01T13:03:32.981673+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Inhibikase raises $4.0M in registered direct offering and warrant inducement

## Summary
- Offering of 1,672,452 shares (or pre-funded warrants) at $1.68/unit with Series A and B warrants.
- Warrant inducement: immediate exercise of 708,500 existing warrants at $1.68; repricing of 1,229,484 warrants.
- Series A/C warrants exercisable 12 months; Series B/D warrants exercisable 5 years from stockholder approval.
- Gross proceeds ~$4.0M; expected closing May 22, 2024; Maxim Group sole placement agent.
- Proceeds for general corporate purposes; stockholder approval required for warrant exercisability.

## SEC filing metadata
- accession: 0001193125-24-142317
- form_type: 8-K
- ticker: IKT
- cik: 0001750149
- company_name: Inhibikase Therapeutics, Inc.
- filed_at: 2024-05-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1750149/000119312524142317/0001193125-24-142317-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1750149/000119312524142317/d768660d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-142317
- JSON: https://secwatch.observer/filing/0001193125-24-142317.json
- Plain text: https://secwatch.observer/filing/0001193125-24-142317.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.